Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays-Reference-Cited by-同舟云学术

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays

Published:2021-12-22 Issue:3 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Chapuy-Regaud Sabine¹²,Miédougé Marcel¹,Abravanel Florence¹²,Da Silva Isabelle¹,Porcheron Marion¹,Fillaux Judith³,Diméglio Chloé¹²,Izopet Jacques¹²^ORCID

Affiliation:

1. Department of Virology, CHU Purpan, Toulouse, France

2. INFINITy (Institut Toulousain des Maladies Infectieuses et Inflammatoires) INSERM UMR1291/CNRS UMR5051/Université Toulouse III, CHU Purpan, Toulouse, France

3. Department of Parasitology, CHU Purpan, Toulouse, France

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 and caused a dramatic pandemic. Serological assays are used to check for immunization and assess herd immunity.

Funder

Centre Hospitalier Universitaire de Toulouse

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01376-21

Reference37 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2

3. Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.